WO2005013834A1 - Tamponade balloon assembly - Google Patents

Tamponade balloon assembly Download PDF

Info

Publication number
WO2005013834A1
WO2005013834A1 PCT/GB2004/003372 GB2004003372W WO2005013834A1 WO 2005013834 A1 WO2005013834 A1 WO 2005013834A1 GB 2004003372 W GB2004003372 W GB 2004003372W WO 2005013834 A1 WO2005013834 A1 WO 2005013834A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
tamponade
tube
drainage tube
interior
Prior art date
Application number
PCT/GB2004/003372
Other languages
French (fr)
Inventor
Sabaratnam Arulkumaran
Original Assignee
St George's Enterprises Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St George's Enterprises Limited filed Critical St George's Enterprises Limited
Publication of WO2005013834A1 publication Critical patent/WO2005013834A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension

Definitions

  • the invention relates to a tamponade balloon assembly suitable for preventing or staunching bleeding in body cavities. It is particularly suitable with a control of bleeding from the uterus resulting from post partum haemorrhage.
  • the invention provides a tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon, the point of attachment of the filling tube to the balloon defining a proximal end of the balloon; a drainage tube, attached to said balloon, and having an open end located towards the distal end of the balloon; and pressure sensing means operably connected to the interior of the balloon.
  • the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration. More preferably, the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
  • a tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon; a drainage tube, attached to said balloon; and pressure sensing means located within the interior of the balloon.
  • the pressure sensing means is located wholly within the interior of the balloon.
  • the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration. More preferably, the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
  • Figure 1 is a schematic diagram illustrating a tamponade balloon according to the present invention.
  • Figure 2 is a cross-section through a tamponade balloon of the present invention showing the relationship between the filling tube, drain tube and pressure sensing element.
  • Figure 3 is a partial cross-section through part of a tamponade balloon assembly according to the present invention and illustrating a preferred means of arranging the filling tube, drain tube and pressure signal.
  • Figure 4 is a cross-section through part of the tamponade balloon assembly.
  • Figures 5 and 6 are cross-sections through part of the tamponade balloon, illustrating the location of the drain tube.
  • FIG. 1 is a schematic diagram illustrating the overall structure of a tamponade balloon assembly, generally indicated as 1, according to the present invention.
  • the assembly comprises an expandable balloon 2, sized and shaped so as to apply pressure to the walls of the body cavity, in use, when it is in its expanded configuration.
  • the balloon will be approximately pear shaped with an overall length of around 15cm, and a width of around 10cm.
  • the tamponade balloon assembly would also find application in staunching bleeding in other body cavities, such as from the pelvic area following hysterectomy. Knowledge of the anatomy of the target body cavity will allow a person skilled in the art to choose a suitable size of balloon.
  • a filling tube 3 in fluid communication with the interior 4 of the expandable balloon 2. This allows a fluid to be introduced and removed from the balloon 2 to adjust its expansion.
  • the point of attachment of the filling tube 3 to the balloon 2 defines a proximal end 5 of the balloon 2.
  • the filling tube 3 will, for convenience of use, be fitted with a valve arrangement to seal the fluid inside the balloon after filling.
  • a drainage tube 7 This tube allows for drainage of blood and other body materials from the body cavity.
  • the drainage tube 7 has an open end 8 located towards the distal end 6 of the balloon 2.
  • the drainage tube 7 could be located on the outside of the balloon 2 but it is particularly advantageous that it enters the proximal end 5 of the balloon, passes through the interior 4 of the balloon and exits at the distal end 6. In this way, the surface of the balloon may be kept relatively smooth so providing an even tamponade effect and preventing the drainage tube 7 from being squeezed shut.
  • pressure sensing means 9 operably connected to the interior of the balloon to measure the pressure therein.
  • the pressure sensing means 9 will have the means to transmit its reading to the outside of the body. In this embodiment, this is achieved by the use of a wire 10 connected to a pressure display unit 11. It could be envisaged that the pressure sensing means 9 could be wholly contained within the interior 4 of the balloon 2 and transmit its signal in a wireless mode by use of suitable transponding devices.
  • Figure 2 is a partial cross-section of a particularly preferred embodiment of a tamponade balloon 2 forming part of an overall tamponade balloon assembly.
  • the filling tube 3 passes through the outer surface of the balloon 2, so defining a distal end 5 of the balloon 2 and affixed to the proximal end of the balloon 6.
  • the filling tube 3 is in fluid communication with the interior of the balloon 4 via one or more holes 12 in the wall of the filling tube 3.
  • the drainage tube 7 is located within the filling tube 3 and is arranged to have an open end 8 toward the distal end 6 of the balloon 2.
  • the filling tube may advantageously be made from a flexible plastics material, capable of being bent into shape by a supervising clinician (to assist in fitting the device) and retaining that shape for at least long enough to fit the device.
  • a supervising clinician to assist in fitting the device
  • the skilled addressee will be able to choose a suitable material.
  • the pressure sensing means 9 is itself a flexible, air-filled balloon, the outer surface of which is in fluid communication with the interior 4 of the tamponade balloon 2 via the lumen of the filling tube 3 and the hole 12.
  • Pressure sensing devices of this form are known in themselves and are commonly used as intrauterine pressure monitors.
  • the skilled addressee is referred to US patent 5,951,497 for details of construction and operation, hi this embodiment, the pressure sensing means 9 transmits its signal via a column of air within another tube 10 towards the other end of the assembly, illustrated in figure 3. To more clearly illustrate the arrangement of tubes in this assembly, a cross-section marked A-A will be illustrated and described below.
  • the portion of the tamponade balloon assembly illustrated in figure 2 is that which fits within the body cavity in use. It is connected via its tube arrangement to the external portion illustrated in figure 3.
  • Figure 3 illustrates how the drainage tube 7 may conveniently be routed through the side wall of the filling tube 3 to an exit port 13. Any blood or other material that drains through the drainage tube 7 may thereby be either collected or observed as it leaves the drainage port 13.
  • the pressure signal tube 10 is in operable communication with a pressure sensing port 14 for connection to a suitable measurement and display device. Such devices are commonly used with the intrauterine pressure measurement device described in US patent 5,951,497.
  • the drainage tube 3 is in fluid connection with filling ports 15 and 16, via a three-way valve 17. Operation of the valve allows fluid to be introduced into and removed from the interior of the balloon.
  • Figure 4 is the section A-A of figure 2 illustrating how, in this most preferred embodiment, the drainage tube 7 and the pressure sensing tube 10 are located within the lumen 18 of the filling tube 3.
  • the open end 8 of the drainage tube 7 is substantially flush with the surface of the balloon when in its expanded configuration. This feature is to stop the end of the drainage tube 7 from kinking and so blocking the tube 7.
  • Figure 5 illustrates one such arrangement where the drainage tube 7 passes through the surface of the balloon 2 so that its open end 8 is substantially flush with the surface of the balloon, indicated by the dotted line, hi this configuration, the tube 7 protrudes by a small distance P.
  • this distance P is small enough that the tube 7 cannot kink.
  • this distance P should be less than the tube diameter, D.
  • the distance P could be slightly larger than D.
  • Figure 6 shows a further, and most particularly preferred embodiment of the invention, where the open end 8 of the drainage tube 7 is recessed below the surface of the balloon 2 when in its expanded configuration.
  • the open end of the tub 8 should be below the convex surface enclosing the actual balloon, indicated by the dotted line 19.
  • the tamponade balloon assembly described herein preferably uses a non-elastic material for manufacture of the balloon itself. This allows the balloon to expand to a maximum size before the internal pressure increases markedly. This therefore prevents over- inflation of the balloon and possible damage to the patient.
  • the balloon In use as an intrauterine device to staunch uterine bleeding, the balloon is inserted into the uterus and warm saline introduced into the interior of the balloon to inflate it.
  • fluid is introduced until the internal pressure equals or exceeds the systemic arterial pressure of the patient, this way, the presence of an internal pressure sensing device allows the tamponade balloon assembly to be operated in a rational way for the prevention of uterine bleeding.
  • the use of the intrauterine pressure sensing system (described in US patent 5,951,497), which is used routinely to measure intra-amniotic pressure and uterine contractions in labour, is particularly advantageous, as a common pressure measuring and display unit can be used for both devices.
  • the tamponade balloon 2 is built around the pressure sensing area of this device.
  • the tamponade balloon is introduced into the uterine cavity and filled with fluid.
  • the pressure-sensing catheter which is now covered within the balloon with the fluid inside can be connected to the pressure measuring device.
  • This device can be kept by the bedside to read out the pressure in eg. a digital format.
  • the intrauterine catheter can be connected to a foetal monitor to read the pressure.
  • the pressure measurement allows the supervising clinician to fill the tamponade balloon until the desired pressure is reached, typically a little above the systolic blood pressure of the patient.
  • the tamponade By maintaining the pressure within the balloon, the tamponade can be maintained over 6 to 12 hours. This will allow the blood vessels to be sealed off by clotting mechanisms. The balloon can then be deflated and taken out. Should there be blood accumulation within the uterine cavity, the pressure within the balloon is likely to increase and this may be monitored via the pressure sensing system and could advantageously be incorporated into the unit with an alarm to signal any pressure increase and thus be indicative of continuing bleeding.
  • the supervising clinician can readily determine whether the tamponade has been successful in staunching the bleeding, and so, in the case of a uterine tamponade balloon, can make a rational decision as to whether the woman needs a laparotomy to control the bleeding.
  • the tamponade balloon assembly will, however, act as a therapeutic intervention by stopping the bleeding in the vast majority of cases. Carried out in time, this test and approach will avoid a large number of women needing blood transfusion, laporotomies and hysterectomies. It may also help to reduce the number of maternal deaths.
  • the care giver in the primary healthcare centre can be trained to introduce and inflate the balloon.
  • the three delay model, which causes maternal death, is well known and by using the tamponade balloon assembly, it is possible to avoid delay in obtaining effective treatment. This will not only save lives but will also avoid transfer to other centres, perhaps several hundred miles distance and avoid unnecessary blood transfusion, laparotomy and hysterectomy.

Abstract

The invention provides and improved tamponade balloon assembly for stanching bleeding from body cavities; it is especially useful for the control of postpartum uterine bleeding. The assemble comprises an expandable balloon, a drain tube and pressure sensing means.

Description

TAMPONADE BALLOON ASSEMBLY
Field of the Invention
The invention relates to a tamponade balloon assembly suitable for preventing or staunching bleeding in body cavities. It is particularly suitable with a control of bleeding from the uterus resulting from post partum haemorrhage.
Background and Review of the Art known to the Applicant
Globally there are 600,000 maternal deaths each year following childbirth. It is estimated that 25% of the deaths are due to post partum haemorrhage. 99% of these deaths take place in developing countries and 1% in developed countries. The deaths in the developing world are generally due to three delays: delay in seeking treatment, in reaching the Hospital and in obtaining the treatment in the Hospital. In the developed world maternal mortality is rare (8-10 maternal deaths in each triennium in the UK), but a number of laparotomies are needed to control the bleeding and many end in hysterectomy. The removal of the uterus prevents these young mothers having more children. During surgery they lose many litres of blood, which needs to be replaced. Some women might need up to 30 units of blood. As a result, the avoidance of haemorrhage remains the principal basis for the active management of the third stage of labour. Initially, ecbolic drugs are used as a prophylactic measure to ensure the maintenance of a well-contracted uterus. Modern management techniques also include the use of prostaglandins. Where these conservative therapies fail to halt blood loss, uterine packing with various configurations of gauze has been used. However, uterine packing has been the subject of much debate with a suggestion that there is significant risk of continued haemorrhage and subsequent infection. As a result, there have been a number of attempts at balloon tamponade, i.e. the use of an inflatable balloon to exert pressure on the uterine wall.
As early as 1983, an inflatable intrauterine device was described in US patent 4,552,557. The device had a shaped, inflatable portion that could be inflated within the uterus to provide tamponade. At its lower end was a drainage channel, attached to the outer surface of the wall of the device to permit drainage of blood from below the inflated unit.
In 1997, the use of a device (known as a Sengstaken-Blakemore balloon) having two inflatable portions was described for the control of post-partum haemorrhage (International Journal of Gynaecology and Obstetrics 58 (1997) 251 - 252, Chan, C. et al).
In the same year, a complex device for staunching uterine bleeding was described in US patent number 6024753. This device had an expandable balloon and handle and was provided with a peristaltic pump for introduction of fluid into the balloon. The device was provided with an external pressure sensing element, which provided control signals to the pump to vary the volume of the balloon in response to subsequent contraction of uterus. The drainage systems of earlier devices was abandoned.
In 2001 a tamponade balloon was described (International Journal of Gynaecology and Obstetrics 72 (2001) 139 - 142, Bakri, Y. N. et al) that had an inflatable, elastic balloon with a drainage channel that passed from one side of the balloon to the other and extending approximately half a balloon diameter beyond the balloon. The earlier teaching of the provision of pressure measurement was abandoned. The following year (BJOG: an International Journal of Obstetrics and Gynaecology, August 2002, volume 109, page 963, Danso, D. and Reginald, E.) the use of a bracing suture together with a prostatic balloon catheter was described for treatment of post partum haemorrhage.
Despite almost 20 years of experimentation with balloon tamponade, no one design of device could be said to provide the optimal system for treatment of post partum haemorrhage. It is an object of the present invention to provide a solution to the problems of control of bleeding and indication of success and a rational basis for determination of the appropriate degree of inflation.
Summary of the Invention
In its broadest first aspect, the invention provides a tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon, the point of attachment of the filling tube to the balloon defining a proximal end of the balloon; a drainage tube, attached to said balloon, and having an open end located towards the distal end of the balloon; and pressure sensing means operably connected to the interior of the balloon.
Preferably, the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration. More preferably, the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
hi a second aspect of the invention, there is provided a tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon; a drainage tube, attached to said balloon; and pressure sensing means located within the interior of the balloon.
Preferably, the pressure sensing means is located wholly within the interior of the balloon.
Preferably, the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration. More preferably, the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
Included within the scope if the invention is a tamponade balloon assembly substantially as described herein, with reference to and as illustrated by any appropriate combination of the accompanying drawings.
Brief Description of the Drawings
The invention will now be described with reference to the accompanying drawings in which:
Figure 1 is a schematic diagram illustrating a tamponade balloon according to the present invention.
Figure 2 is a cross-section through a tamponade balloon of the present invention showing the relationship between the filling tube, drain tube and pressure sensing element.
Figure 3 is a partial cross-section through part of a tamponade balloon assembly according to the present invention and illustrating a preferred means of arranging the filling tube, drain tube and pressure signal. Figure 4 is a cross-section through part of the tamponade balloon assembly.
Figures 5 and 6 are cross-sections through part of the tamponade balloon, illustrating the location of the drain tube.
Description of the Prefened Embodiments
Figure 1 is a schematic diagram illustrating the overall structure of a tamponade balloon assembly, generally indicated as 1, according to the present invention. The assembly comprises an expandable balloon 2, sized and shaped so as to apply pressure to the walls of the body cavity, in use, when it is in its expanded configuration. Typically, for use as an intrauterine tamponade device, the balloon will be approximately pear shaped with an overall length of around 15cm, and a width of around 10cm. The tamponade balloon assembly would also find application in staunching bleeding in other body cavities, such as from the pelvic area following hysterectomy. Knowledge of the anatomy of the target body cavity will allow a person skilled in the art to choose a suitable size of balloon.
Also provided is a filling tube 3 in fluid communication with the interior 4 of the expandable balloon 2. This allows a fluid to be introduced and removed from the balloon 2 to adjust its expansion. For reference purposes, the point of attachment of the filling tube 3 to the balloon 2 defines a proximal end 5 of the balloon 2.
The filling tube 3 will, for convenience of use, be fitted with a valve arrangement to seal the fluid inside the balloon after filling.
Also provided is a drainage tube 7. This tube allows for drainage of blood and other body materials from the body cavity. In one particularly preferred invention, to be described in more detail below, the drainage tube 7 has an open end 8 located towards the distal end 6 of the balloon 2. The drainage tube 7 could be located on the outside of the balloon 2 but it is particularly advantageous that it enters the proximal end 5 of the balloon, passes through the interior 4 of the balloon and exits at the distal end 6. In this way, the surface of the balloon may be kept relatively smooth so providing an even tamponade effect and preventing the drainage tube 7 from being squeezed shut.
Also provided is pressure sensing means 9 operably connected to the interior of the balloon to measure the pressure therein. A number of pressure sensing devices will be known to those skilled in the art and a particularly preferred embodiment will be described below. The pressure sensing means 9 will have the means to transmit its reading to the outside of the body. In this embodiment, this is achieved by the use of a wire 10 connected to a pressure display unit 11. It could be envisaged that the pressure sensing means 9 could be wholly contained within the interior 4 of the balloon 2 and transmit its signal in a wireless mode by use of suitable transponding devices.
Figure 2 is a partial cross-section of a particularly preferred embodiment of a tamponade balloon 2 forming part of an overall tamponade balloon assembly. In this embodiment, the filling tube 3 passes through the outer surface of the balloon 2, so defining a distal end 5 of the balloon 2 and affixed to the proximal end of the balloon 6. The filling tube 3 is in fluid communication with the interior of the balloon 4 via one or more holes 12 in the wall of the filling tube 3. The drainage tube 7 is located within the filling tube 3 and is arranged to have an open end 8 toward the distal end 6 of the balloon 2. In this embodiment, the filling tube may advantageously be made from a flexible plastics material, capable of being bent into shape by a supervising clinician (to assist in fitting the device) and retaining that shape for at least long enough to fit the device. Given this teaching, the skilled addressee will be able to choose a suitable material.
Also located within the filling tube 3 is the pressure sensing means 9. In this particularly preferred embodiment, the pressure sensing means 9 is itself a flexible, air-filled balloon, the outer surface of which is in fluid communication with the interior 4 of the tamponade balloon 2 via the lumen of the filling tube 3 and the hole 12. Pressure sensing devices of this form are known in themselves and are commonly used as intrauterine pressure monitors. The skilled addressee is referred to US patent 5,951,497 for details of construction and operation, hi this embodiment, the pressure sensing means 9 transmits its signal via a column of air within another tube 10 towards the other end of the assembly, illustrated in figure 3. To more clearly illustrate the arrangement of tubes in this assembly, a cross-section marked A-A will be illustrated and described below.
The portion of the tamponade balloon assembly illustrated in figure 2 is that which fits within the body cavity in use. It is connected via its tube arrangement to the external portion illustrated in figure 3. Figure 3 illustrates how the drainage tube 7 may conveniently be routed through the side wall of the filling tube 3 to an exit port 13. Any blood or other material that drains through the drainage tube 7 may thereby be either collected or observed as it leaves the drainage port 13. The pressure signal tube 10 is in operable communication with a pressure sensing port 14 for connection to a suitable measurement and display device. Such devices are commonly used with the intrauterine pressure measurement device described in US patent 5,951,497. The drainage tube 3 is in fluid connection with filling ports 15 and 16, via a three-way valve 17. Operation of the valve allows fluid to be introduced into and removed from the interior of the balloon.
Figure 4 is the section A-A of figure 2 illustrating how, in this most preferred embodiment, the drainage tube 7 and the pressure sensing tube 10 are located within the lumen 18 of the filling tube 3.
It is particularly preferable in any embodiment of the tamponade balloon assembly that the open end 8 of the drainage tube 7 is substantially flush with the surface of the balloon when in its expanded configuration. This feature is to stop the end of the drainage tube 7 from kinking and so blocking the tube 7. Figure 5 illustrates one such arrangement where the drainage tube 7 passes through the surface of the balloon 2 so that its open end 8 is substantially flush with the surface of the balloon, indicated by the dotted line, hi this configuration, the tube 7 protrudes by a small distance P. By 'substantially flush' it is meant that this distance P is small enough that the tube 7 cannot kink. For a particularly flexible tube, this distance P should be less than the tube diameter, D. For a less flexible tube, the distance P could be slightly larger than D. Given this teaching, it will be apparent to those skilled in the art how long they may allow the tube 7 to protrude through this surface of the balloon 2. Figure 6 shows a further, and most particularly preferred embodiment of the invention, where the open end 8 of the drainage tube 7 is recessed below the surface of the balloon 2 when in its expanded configuration. By 'recessed below the surface', we mean that the open end of the tub 8 should be below the convex surface enclosing the actual balloon, indicated by the dotted line 19.
The tamponade balloon assembly described herein preferably uses a non-elastic material for manufacture of the balloon itself. This allows the balloon to expand to a maximum size before the internal pressure increases markedly. This therefore prevents over- inflation of the balloon and possible damage to the patient.
Use of the Device
In use as an intrauterine device to staunch uterine bleeding, the balloon is inserted into the uterus and warm saline introduced into the interior of the balloon to inflate it. Using the pressure sensing means, fluid is introduced until the internal pressure equals or exceeds the systemic arterial pressure of the patient, this way, the presence of an internal pressure sensing device allows the tamponade balloon assembly to be operated in a rational way for the prevention of uterine bleeding.
The use of the intrauterine pressure sensing system (described in US patent 5,951,497), which is used routinely to measure intra-amniotic pressure and uterine contractions in labour, is particularly advantageous, as a common pressure measuring and display unit can be used for both devices. The tamponade balloon 2 is built around the pressure sensing area of this device. The tamponade balloon is introduced into the uterine cavity and filled with fluid. The pressure-sensing catheter, which is now covered within the balloon with the fluid inside can be connected to the pressure measuring device. This device can be kept by the bedside to read out the pressure in eg. a digital format. Alternatively, the intrauterine catheter can be connected to a foetal monitor to read the pressure. The pressure measurement allows the supervising clinician to fill the tamponade balloon until the desired pressure is reached, typically a little above the systolic blood pressure of the patient.
By maintaining the pressure within the balloon, the tamponade can be maintained over 6 to 12 hours. This will allow the blood vessels to be sealed off by clotting mechanisms. The balloon can then be deflated and taken out. Should there be blood accumulation within the uterine cavity, the pressure within the balloon is likely to increase and this may be monitored via the pressure sensing system and could advantageously be incorporated into the unit with an alarm to signal any pressure increase and thus be indicative of continuing bleeding.
By monitoring any blood that may emerge from the drainage tube, the supervising clinician can readily determine whether the tamponade has been successful in staunching the bleeding, and so, in the case of a uterine tamponade balloon, can make a rational decision as to whether the woman needs a laparotomy to control the bleeding. The tamponade balloon assembly will, however, act as a therapeutic intervention by stopping the bleeding in the vast majority of cases. Carried out in time, this test and approach will avoid a large number of women needing blood transfusion, laporotomies and hysterectomies. It may also help to reduce the number of maternal deaths. It will be especially helpful in developing countries as most of the deaths take place while waiting to go to the Hospital from a primary healthcare centre. The care giver in the primary healthcare centre can be trained to introduce and inflate the balloon. The three delay model, which causes maternal death, is well known and by using the tamponade balloon assembly, it is possible to avoid delay in obtaining effective treatment. This will not only save lives but will also avoid transfer to other centres, perhaps several hundred miles distance and avoid unnecessary blood transfusion, laparotomy and hysterectomy.

Claims

Claims
1. A tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon, the point of attachment of the filling tube to the balloon defining a proximal end of the balloon; a drainage tube, attached to said balloon, and having an open end located towards the distal end of the balloon; and pressure sensing means operably connected to the interior of the balloon.
2. A tamponade balloon assembly according to claim 1 wherein the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration.
3. A tamponade balloon assembly according to claim 1 wherein the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
4. A tamponade balloon assembly comprising: an expandable balloon, so sized and shaped so as to apply pressure to the walls of a body cavity, in use, when in its expanded configuration; a filling tube, in fluid communication with the interior of the expandable balloon, to allow a fluid to be introduced and removed from the balloon, so adjusting the expansion of the balloon; a drainage tube, attached to said balloon; and pressure sensing means located within the interior of the balloon.
5. A tamponade balloon assembly according to claim 4, wherein the pressure sensing means is located wholly within the interior of the balloon.
6. A tamponade balloon assembly according to either of claims 4 and 5 wherein the open end of the drainage tube is substantially flush with the surface of the balloon when in its expanded configuration.
7. A tamponade balloon assembly according to either of claims 4 and 5 wherein the open end of the drainage tube is recessed below the surface of the balloon when in its expanded configuration.
8. A tamponade balloon assembly substantially as described herein, with reference to and as illustrated by any appropriate combination of the accompanying drawings.
PCT/GB2004/003372 2003-08-06 2004-08-05 Tamponade balloon assembly WO2005013834A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0318425.6 2003-08-06
GBGB0318425.6A GB0318425D0 (en) 2003-08-06 2003-08-06 Koala pph tamponade test balloon

Publications (1)

Publication Number Publication Date
WO2005013834A1 true WO2005013834A1 (en) 2005-02-17

Family

ID=27839735

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/003372 WO2005013834A1 (en) 2003-08-06 2004-08-05 Tamponade balloon assembly

Country Status (2)

Country Link
GB (1) GB0318425D0 (en)
WO (1) WO2005013834A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089516A1 (en) * 2007-01-25 2008-07-31 Level Three Innovations Pty Ltd Canal dilation device
CN104116540A (en) * 2013-04-27 2014-10-29 耿桂启 Temporary in vitro uterine artery blocker
CN104622532A (en) * 2014-12-30 2015-05-20 陈世伟 Air bag type kidney part blocking device
US9055949B2 (en) 2007-02-09 2015-06-16 B & D Medical Development, Llc Balloon tamponade
CN105662518A (en) * 2016-03-09 2016-06-15 中国人民解放军第三军医大学第一附属医院 Intelligent uterus hemostasis air bag
CN106691531A (en) * 2017-01-06 2017-05-24 王琳 Emergency bleeding stopping bag for uteruses
GB2560963A (en) * 2017-03-30 2018-10-03 Varma Rajiv A balloon tamponade device
WO2018222296A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring uterine contraction pressure
WO2018222295A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure
WO2018222557A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring pressure for muscle compartment syndrome
EP3656297A1 (en) * 2018-11-24 2020-05-27 Sentinel Medical Technologies, LLC Catheter for monitoring pressure
US20200253536A1 (en) * 2019-02-08 2020-08-13 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure for assessing preeclampsia
US10799131B2 (en) 2017-06-03 2020-10-13 Sentinel Medical Technologies, LLC Catheter for monitoring intrauterine pressure to protect the fallopian tubes
WO2021026020A1 (en) * 2019-08-08 2021-02-11 Sentinel Medical Technologies, LLC Cable for use with pressure monitoring catheters
CN112368048A (en) * 2018-07-10 2021-02-12 奥林巴斯株式会社 Phototherapy support device, phototherapy system, and phototherapy support method
US11045143B2 (en) 2017-06-03 2021-06-29 Sentinel Medical Technologies, LLC Catheter with connectable hub for monitoring pressure
US11185245B2 (en) 2017-06-03 2021-11-30 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure for muscle compartment syndrome
EP3878385A4 (en) * 2018-11-08 2022-08-31 Alonso Pacheco, Luis Intrauterine expander device
US11617543B2 (en) 2019-12-30 2023-04-04 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552557A (en) 1983-10-21 1985-11-12 Avvari Rangaswamy Inflatable uterine hemostat
US5951497A (en) 1996-09-03 1999-09-14 Clinical Innovation Associates, Inc. Pressure catheter device with enhanced positioning features
US6024753A (en) 1996-02-05 2000-02-15 Atos Medical Ab Device for staunching uterus bleeding
US6206868B1 (en) * 1998-03-13 2001-03-27 Arteria Medical Science, Inc. Protective device and method against embolization during treatment of carotid artery disease
WO2002024085A1 (en) * 2000-09-20 2002-03-28 Uro Devices Limited Device for staunching vagina bleeding
DE10208508A1 (en) * 2001-06-29 2003-01-16 Univ Goettingen Georg August Uterus operation instruments comprise manipulator and pertubation bar has attachments and balloon at distal and proximal ends, and suction device
WO2003032847A1 (en) * 2001-10-17 2003-04-24 Atos Medical Ab A device for controlling bleeding and a method for producing the device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552557A (en) 1983-10-21 1985-11-12 Avvari Rangaswamy Inflatable uterine hemostat
US6024753A (en) 1996-02-05 2000-02-15 Atos Medical Ab Device for staunching uterus bleeding
US5951497A (en) 1996-09-03 1999-09-14 Clinical Innovation Associates, Inc. Pressure catheter device with enhanced positioning features
US6206868B1 (en) * 1998-03-13 2001-03-27 Arteria Medical Science, Inc. Protective device and method against embolization during treatment of carotid artery disease
WO2002024085A1 (en) * 2000-09-20 2002-03-28 Uro Devices Limited Device for staunching vagina bleeding
DE10208508A1 (en) * 2001-06-29 2003-01-16 Univ Goettingen Georg August Uterus operation instruments comprise manipulator and pertubation bar has attachments and balloon at distal and proximal ends, and suction device
WO2003032847A1 (en) * 2001-10-17 2003-04-24 Atos Medical Ab A device for controlling bleeding and a method for producing the device

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089516A1 (en) * 2007-01-25 2008-07-31 Level Three Innovations Pty Ltd Canal dilation device
US9055949B2 (en) 2007-02-09 2015-06-16 B & D Medical Development, Llc Balloon tamponade
US9888927B2 (en) 2007-02-09 2018-02-13 B & D Medical Development, Llc Balloon tamponade
CN104116540A (en) * 2013-04-27 2014-10-29 耿桂启 Temporary in vitro uterine artery blocker
CN104622532A (en) * 2014-12-30 2015-05-20 陈世伟 Air bag type kidney part blocking device
CN104622532B (en) * 2014-12-30 2017-01-04 陈世伟 A kind of gasbag-type kidney part blocks device
CN105662518A (en) * 2016-03-09 2016-06-15 中国人民解放军第三军医大学第一附属医院 Intelligent uterus hemostasis air bag
CN105662518B (en) * 2016-03-09 2018-06-05 中国人民解放军第三军医大学第一附属医院 Intelligent uterine hemostasis air bag
CN106691531A (en) * 2017-01-06 2017-05-24 王琳 Emergency bleeding stopping bag for uteruses
GB2560963A (en) * 2017-03-30 2018-10-03 Varma Rajiv A balloon tamponade device
CN110709003B (en) * 2017-06-03 2023-01-31 森蒂奈尔医疗技术有限责任公司 Catheter for monitoring uterine contraction pressure
US11045143B2 (en) 2017-06-03 2021-06-29 Sentinel Medical Technologies, LLC Catheter with connectable hub for monitoring pressure
WO2018222557A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring pressure for muscle compartment syndrome
CN110709003A (en) * 2017-06-03 2020-01-17 森蒂奈尔医疗技术有限责任公司 Catheter for monitoring uterine contraction pressure
CN110996764A (en) * 2017-06-03 2020-04-10 森蒂奈尔医疗技术有限责任公司 Catheter for monitoring intra-abdominal pressure
US11832947B2 (en) 2017-06-03 2023-12-05 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure
JP2020522330A (en) * 2017-06-03 2020-07-30 センティネル メディカル テクノロジーズ リミテッド ライアビリティ カンパニー Catheter for monitoring uterine contraction pressure
JP2020522309A (en) * 2017-06-03 2020-07-30 センティネル メディカル テクノロジーズ リミテッド ライアビリティ カンパニー Catheter for monitoring abdominal pressure
JP7293135B2 (en) 2017-06-03 2023-06-19 センティネル メディカル テクノロジーズ リミテッド ライアビリティ カンパニー Catheter to monitor intra-abdominal pressure
US10799131B2 (en) 2017-06-03 2020-10-13 Sentinel Medical Technologies, LLC Catheter for monitoring intrauterine pressure to protect the fallopian tubes
US10813589B2 (en) 2017-06-03 2020-10-27 Sentinel Medical Technologies, LLC Catheter for monitoring uterine contraction pressure
JP7282690B2 (en) 2017-06-03 2023-05-29 センティネル メディカル テクノロジーズ リミテッド ライアビリティ カンパニー Catheter for monitoring uterine contraction pressure
CN110996764B (en) * 2017-06-03 2023-02-28 森蒂奈尔医疗技术有限责任公司 Catheter for monitoring intra-abdominal pressure
WO2018222295A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure
US11045128B2 (en) * 2017-06-03 2021-06-29 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure
US11185245B2 (en) 2017-06-03 2021-11-30 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure for muscle compartment syndrome
WO2018222296A1 (en) * 2017-06-03 2018-12-06 Sentinel Medical Technologies, LLC Catheter for monitoring uterine contraction pressure
CN112368048A (en) * 2018-07-10 2021-02-12 奥林巴斯株式会社 Phototherapy support device, phototherapy system, and phototherapy support method
EP3878385A4 (en) * 2018-11-08 2022-08-31 Alonso Pacheco, Luis Intrauterine expander device
US11672457B2 (en) 2018-11-24 2023-06-13 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure
EP3656297A1 (en) * 2018-11-24 2020-05-27 Sentinel Medical Technologies, LLC Catheter for monitoring pressure
US20200253536A1 (en) * 2019-02-08 2020-08-13 Sentinel Medical Technologies, LLC Catheter for monitoring intra-abdominal pressure for assessing preeclampsia
US11779263B2 (en) 2019-02-08 2023-10-10 Sentinel Medical Technologies, Llc. Catheter for monitoring intra-abdominal pressure for assessing preeclampsia
WO2021026020A1 (en) * 2019-08-08 2021-02-11 Sentinel Medical Technologies, LLC Cable for use with pressure monitoring catheters
US11730385B2 (en) 2019-08-08 2023-08-22 Sentinel Medical Technologies, LLC Cable for use with pressure monitoring catheters
US11617543B2 (en) 2019-12-30 2023-04-04 Sentinel Medical Technologies, Llc. Catheter for monitoring pressure

Also Published As

Publication number Publication date
GB0318425D0 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
WO2005013834A1 (en) Tamponade balloon assembly
JP7282690B2 (en) Catheter for monitoring uterine contraction pressure
ES2714583T3 (en) Pelvic balloon tamponade
CA1213491A (en) Inflatable uterine hemostat
US20060173486A1 (en) Device for staunching postpartum haemorrhage
US6175751B1 (en) Apparatus and method for sensing oxygen levels in a fetus
JPS6220828B2 (en)
US20170035949A1 (en) Drainage system and vacuum pump for intrauterine vacuum therapy
KR101903591B1 (en) balloon catheter with hemostasis for vaginal bleeding
US8123773B1 (en) Postpartum hemorrhage balloon tamponade catheter
US20150238226A1 (en) Zhukovsky double-balloon obstetric catheter
US20180000488A1 (en) Inflatable intrauterine balloon
Danso et al. Internal uterine tamponade
US11839408B2 (en) Systems, devices, and methods for uterine hemostasis
Kekre et al. Spontaneous rupture of the urinary bladder in the puerperium
CN219557439U (en) Hemostatic balloon
CN214434356U (en) Intrauterine hemostatic forceps for obstetrics and gynecology department
CN214912453U (en) Novel double-cavity double-tube single-bag anal tube
CN218979467U (en) Postoperative care belt
CN213724000U (en) Uterine cavity perfusate collection device
CN219070886U (en) Inflatable intestinal stoma dilator
CN213589489U (en) Drainage tube for operation of severe patient in obstetrics and gynecology department
WO2005030064A1 (en) A device for staunching postpartum haemorrhage
Atad et al. Continuous extraovular prostaglandin F2 alpha instillation for late pregnancy termination in patients with previous cesarean section delivery
CN218484995U (en) Uterine cavity perfusion drainage device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase